4 November 2024 false Taxfiler 2024.6 16057534business:PrivateLimitedCompanyLtd2024-11-042025-11-30 160575342024-11-03 160575342024-11-042025-11-30 16057534business:AuditExemptWithAccountantsReport2024-11-042025-11-30 16057534business:FilletedAccounts2024-11-042025-11-30 160575342025-11-30 16057534business:Director12024-11-042025-11-30 16057534business:Director22024-11-042025-11-30 16057534business:RegisteredOffice2024-11-042025-11-30 16057534core:WithinOneYear2025-11-30 16057534core:ShareCapitalcore:PreviouslyStatedAmount2025-11-30 16057534core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-11-30 16057534core:PreviouslyStatedAmount2025-11-30 16057534business:SmallEntities2024-11-042025-11-30 16057534countries:EnglandWales2024-11-042025-11-30 16057534business:OrdinaryShareClass12024-11-042025-11-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 16057534 (England and Wales)
Jupiter Laboratories Ltd Unaudited accounts for the period from 4 November 2024 to 30 November 2025
Jupiter Laboratories Ltd Unaudited accounts Contents
Page
- 2 -
Jupiter Laboratories Ltd Company Information for the period from 4 November 2024 to 30 November 2025
Directors
Samuel Durso Thomas Joyce
Company Number
16057534 (England and Wales)
Registered Office
4th Floor Office 205 Regent Street London W1B 4HB England
Accountants
Sleek Accounting Ltd 4th Floor 205 Regent Street London W1B 4HB
- 3 -
Jupiter Laboratories Ltd Statement of financial position as at 30 November 2025
2025 
Notes
£ 
Current assets
Inventories
28,138 
Debtors
2,307 
Cash at bank and in hand
60,855 
91,300 
Creditors: amounts falling due within one year
(86,408)
Net current assets
4,892 
Net assets
4,892 
Capital and reserves
Called up share capital
100 
Profit and loss account
4,792 
Shareholders' funds
4,892 
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 27 October 2026 and were signed on its behalf by
Samuel Durso Director Company Registration No. 16057534
- 4 -
Jupiter Laboratories Ltd Notes to the Accounts for the period from 4 November 2024 to 30 November 2025
1
Statutory information
Jupiter Laboratories Ltd is a private company, limited by shares, registered in England and Wales, registration number 16057534. The registered office is 4th Floor Office, 205 Regent Street, London, W1B 4HB, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
These financial statements for the period from 4 November 2024 to 30 November 2025 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 4 November 2024. The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously. The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
4
Debtors
2025 
£ 
Amounts falling due within one year
Other debtors
2,307 
- 5 -
Jupiter Laboratories Ltd Notes to the Accounts for the period from 4 November 2024 to 30 November 2025
5
Creditors: amounts falling due within one year
2025 
£ 
Bank loans and overdrafts
4,180 
VAT
3,809 
Trade creditors
61,197 
Taxes and social security
5,814 
Loans from directors
11,408 
86,408 
6
Share capital
2025 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
7
Average number of employees
During the period the average number of employees was 0.
- 6 -